Variable | Total (n = 554 133) | Polypharmacy | |
---|---|---|---|
No (n = 354 648) | Yes (n = 199 485) | ||
Socio-demographic | |||
Age (year); Median (IQR) | 51 (40 – 62) yr | 51 (39 – 61) yr | 52 (41 – 63) yr |
Gender | |||
 Female | 346 569 (62.5%) | 221 554 (62.5%) | 125 015 (62.7%) |
 Male | 207 564 (37.5%) | 133 094 (37.5%) | 74 470 (37.3%) |
Marital status | |||
 Single | 202 258 (36.5%) | 131 574 (37.1%) | 70 684 (35.4%) |
 Married | 351 875 (63.5%) | 226 265 (63.8%) | 125 610 (63.0%) |
Employment status | |||
 Employed | 461 039 (83.2%) | 294 358 (83.0%) | 166 681 (83.6%) |
 Unemployed | 93 094 (16.8%) | 61 354 (17.1%) | 31 740 (15.9%) |
Income | |||
 Low | 231 384 (41.8%) | 148 598 (41.9%) | 82 786 (41.5%) |
 Middle | 193 578 (34.9%) | 123 559 (34.8%) | 70 019 (35.1%) |
 High | 129 312 (23.3%) | 82 633 (23.3%) | 46 679 (23.4%) |
Residence area | |||
 Urban | 434 839 (78.5%) | 278 044 (78.4%) | 156 795 (78.6%) |
 Rural | 119 294 (21.5%) | 76 604 (21.6%) | 42 690 (21.4%) |
Ethnicity | |||
 Arab | 184 614 (33.3%) | 117 388 (33.1%) | 67 226 (33.7%) |
 Fars | 179 450 (32.4%) | 115 615 (32.6%) | 63 835 (32.0%) |
 Lor | 167 548 (30.2%) | 107 104 (30.2%) | 60 444 (30.3%) |
 Tork & Kord | 22 521 (4.1%) | 14 541 (4.1%) | 7 980 (4.0%) |
Prescriptions | |||
Season | |||
 Spring | 132 991 (24.0%) | 85 115 (24.0%) | 47 876 (24.0%) |
 Summer | 131 130 (23.7%) | 84 052 (23.7%) | 47 078 (23.6%) |
 Autumn | 146 491 (26.4%) | 93 627 (26.4%) | 52 864 (26.5%) |
 Winter | 143 521 (25.9%) | 91 854 (25.9%) | 51 667 (25.9%) |
TPS $; Median (IQR), per persc/y | 4.4 (2.1 – 10.3) $ | 2.9 (1.5 – 6.7) $ | 7.7 (4.4 – 14.8) $ |
NOP; Median (IQR), per year | 2.7 (1.4 – 4.3) | 2.6 (1.4 – 4.3) | 2.7 (1.5 – 4.4) |
NOD; Median (IQR), per persc/y | 4.7 (2.1 – 6.4) | 3.8 (2.5 – 5.6) | 4.2 (3.7 – 7.1) |
ICPD $; Median (IQR), per persc/y | 1.3 (0.9 – 1.8)$ | 1.3 (0.9 – 1.8)$ | 1.4 (0.9 – 1.9)$ |
NVGP; Median (IQR), per year | 2.2 (1.4 – 4.6) | 2.1 (2.0 – 3.9) | 2.2 (2.0 – 4.1) |
NVS; Median (IQR), per year | 2.3 (1.5 – 4.7) | 2.2 (1.9 – 3.7) | 2.3 (2.1 – 4.1) |
Comorbidity | |||
Any comorbidity | 169 942 (30.7%) | 107 104 (30.2%) | 62 838 (31.5%) |
DM | 47 943 (8.7%) | 29 790 (8.4%) | 18 153 (9.1%) |
Asthma | 46 592 (8.4%) | 29 436 (8.3%) | 17 156 (8.6%) |
DLP | 363 135 (65.5%) | 230 876 (65.1%) | 132 259 (66.3%) |
HTN | 209 751 (37.9%) | 130 156 (36.7%) | 79 595 (39.9%) |
GERD | 239 518 (43.2%) | 152 144 (42.9%) | 87 374 (43.7%) |
CVD | 30 699 (5.5%) | 17 732 (5.0%) | 12 967 (6.9%) |
CKD | 47 079 (8.5%) | 28 726 (8.1%) | 18 353 (9.2%) |
RA | 4 581 (0.8%) | 2 766 (0.8%) | 1 815 (0.9%) |
MHC | 119 892 (21.6%) | 76 604 (21.6%) | 43 288 (21.7%) |